Cellectar Biosciences, Inc.
CLRB
Revenue
0.00
0.000.00%
-Assets
29.38M
▼-13.52M▼-31.52%
3 Months ChangeLiabilities
15.62M
▼-13.40M▼-46.18%
3 Months ChangeFree Cash Flow
-13.38M
▼-8.31M▼-163.98%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001104659-24-113549
2024-10-29
Form 10-Q
ID: 0001410578-24-001708
2024-08-23
Form 8-K
ID: 0001104659-24-092495
2024-08-13
Form 8-K
ID: 0001104659-24-088606
2024-08-09
Form 8-K
ID: 0001104659-24-087859
2024-07-23
Form 8-K
ID: 0001104659-24-081680
2024-07-22
Form 8-K
ID: 0001104659-24-081307
2024-07-11
Form 8-K
ID: 0001104659-24-079262
2024-06-25
Form 8-K
ID: 0001104659-24-074747
2024-06-14
Form 8-K
ID: 0001104659-24-071822